Cravath Team Named “Litigators of the Week” by The Am Law Litigation Daily for Successful Defense of Amgen Against FTC’s Challenge to Acquisition of Horizon Therapeutics

On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partners David R. Marriott and Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.

In the Q&A feature, Dave spoke about the Firm’s longstanding work for Amgen on a variety of litigation matters, noting that work to secure clearance of this transaction took “tremendous effort and teamwork” given the FTC’s case was based on a theory never before litigated in court. Doing so required “researching decades old case law, developing counterarguments to new economic theories, as well as old fashioned fact gathering.” Reflecting on what he will remember most about the matter, Dave spoke to the satisfaction of “working with an incredible client to get a deal that will create enormous benefits for patients done. And working with people who are not only great at what they do, but who also care about the important mission of their company.”

In the Q&A, Dave mentioned the contributions of numerous other Cravath lawyers including partners Keith R. Hummel, Rachel G. Skaistis, Margaret T. Segall and Sharonmoyee Goswami, practice area attorneys Benjamin J. Bauer and Omar Debs and associates Hussein Elbashir Elbakri, Catherine G. Sheets, Megan Eloise Vincent, Frances C. McDonald, Kelsey A. Miller, Chizoba D. Ukairo, Kendra M. Kumor and Kristina Stankovic-Kania.

For more detail on the Firm’s representation, please click here to read the related website item.